Art

J-GLOBAL ID：201402254392029811   Reference number：14A1154232

Rapamycin Attenuates Pulmonary Allergic Vasculitis in Murine Model by Reducing TGF-β Production in the Lung

ラパマイシンは肺のTGF-β産生を減少させることによってマウスモデルの肺アレルギー性血管炎を減弱させる

Author (6)： KOIZUMI Rumi (Div. of Pulmonary Medicine, Allergy and Rheumatology, Dep. of Internal Medicine, Iwate Medical Univ. School of Medicine) ,  SASAKI Nobuhito (Div. of Pulmonary Medicine, Allergy and Rheumatology, Dep. of Internal Medicine, Iwate Medical Univ. School of Medicine) ,  NAKAMURA Yutaka (Div. of Pulmonary Medicine, Allergy and Rheumatology, Dep. of Internal Medicine, Iwate Medical Univ. School of Medicine) ,  SUZUKI Naomi (Div. of Pulmonary Medicine, Allergy and Rheumatology, Dep. of Internal Medicine, Iwate Medical Univ. School of Medicine) ,  SAWAI Takashi (Dep. of Pathology, Iwate Medical Univ. School of Medicine) ,  YAMAUCHI Kohei (Div. of Pulmonary Medicine, Allergy and Rheumatology, Dep. of Internal Medicine, Iwate Medical Univ. School of Medicine)
Material： Allergology International  (Allergol Int)
Volume： 63  Issue： 3  Page： 457-466 (J-STAGE)  Publication year： 2014 
JST Material Number： L6446A  ISSN： 1323-8930  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： mouse(animal) ,...
Semi thesaurus term： C57BL/6 mouse ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1154232&from=J-GLOBAL&jstjournalNo=L6446A") }}

JST classification (1)： Basic research of immunotherapeutic agents and blood preparations  (GW22010D)

Substance index (1)： Rapamycin

Reference (36)：

• 1. Savige J, Gillis D, Benson E et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999; 111: 507-13.
• 2. Jennette JC, Falk RJ. Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies? Clin Exp Immunol 1995; 101(Suppl 1): 18-22.
• 3. Hellmich B, Gross WL. Recent progress in the pharmacotherapy of Churg-Strauss syndrome. Expert Opin Pharmacother 2004; 5: 25-35.
• 4. Klion AD, Bochner BS, Gleich GJ et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 2006; 117: 1292-302.
• 5. Keogh KA, Specks U. Churg-Strauss syndrome: update on clinical, laboratory and therapeutic aspects. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23: 3-12.

Terms in the title (6)： ラパマイシン ,  肺 ,  TGF-β ,  マウスモデル ,  アレルギー性血管炎 ,  減弱